絞り込み

16532

広告

Steroid-refractory severe hepatic failure in adult onset Still's disease responding to cyclosporine.

著者 Nagashima T , Aoki Y , Onishi S , Iwamoto M , Okazaki H , Minota S
Clin Rheumatol.2008 Nov ; 27(11):1451-3.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

Division of Rheumatology and Clinical Immunology, Jichi Medical University, Shimotsuke-shi, Tochigi, Japan. naga4ma@jichi.ac.jp

スターを付ける スターを付ける     (534view , 0users)

Full Text Sources

Medical

Miscellaneous

We report two Japanese women with severe hepatic dysfunction and adult onset Still's disease. A 51-year-old woman had been diagnosed with adult onset Still's disease 3 years earlier. She relapsed while on maintenance therapy with prednisolone and methotrexate. After induction of remission with methylprednisolone pulse therapy, indomethacin, and methotrexate, severe hepatic failure occurred. This patient lacked the typical symptoms of adult onset Still's disease. The second patient was a 32-year-old woman with typical adult onset Still's disease. Remission was induced by high-dose prednisolone and methylprednisolone pulse therapy plus cyclosporine. After she stopped cyclosporine, severe liver dysfunction occurred. In both patients, liver dysfunction occurred during high-dose steroid therapy, and oral cyclosporine (3 mg/kg per day) dramatically improved their liver function. When steroid-resistant severe hepatic failure occurs in patients with adult onset Still's disease, cyclosporine may be the immunosuppressant of choice.
PMID: 18592135 [PubMed - indexed for MEDLINE]
印刷用ページを開く Endnote用テキストダウンロード